PTGER4 and brain neoplasm: Importantly, the epigenetic regulation of PTGER4 gene expression by DNA methylation could represent a valuable biomarker to be further developed as a predictor of drug response, particularly taking into account the roll out of methylation-based classification approaches18 in brain tumours.